Previous Close | 126.16 |
Open | 123.69 |
Bid | 0.00 x 1200 |
Ask | 0.00 x 1100 |
Day's Range | 123.21 - 125.85 |
52 Week Range | 75.56 - 138.28 |
Volume | |
Avg. Volume | 5,016,329 |
Market Cap | 561.191B |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | 47.11 |
EPS (TTM) | 2.67 |
Earnings Date | N/A |
Forward Dividend & Yield | 1.37 (1.09%) |
Ex-Dividend Date | Mar 22, 2024 |
1y Target Est | 145.27 |
Lilly is soon planning to ask global regulators to approve tirzepatide for sleep apnea treatment. Is Eli Lilly stock a buy?
Eli Lilly, Novo Nordisk, Merck and AbbVie are part of the Zacks Industry Outlook article.
In the latest trading session, Novo Nordisk (NVO) closed at $126.16, marking a -1.93% move from the previous day.